Oklo to Advance Groves 2 Forge as Part of U.S. Department of Energy’s Nuclear Energy Launch Pad Sele

Started by Marlin, Oct 14, 2026, 09:58

Previous topic - Next topic

0 Members and 0 Guests are viewing this topic.

department of energyoklogroves 2 forgelutetium-177

Marlin


Core Content

Twitter

Oklo Inc. plans to develop the Groves 2 Forge facility following its selection by the United States Department of Energy. The installation combines reactor irradiation with hot-cell processing operations. Operations will target lutetium-177 and other therapeutic isotopes for radiopharmaceutical manufacturing.

Many medical isotopes rely on aging or foreign infrastructure, creating supply chain vulnerabilities for domestic healthcare providers. Expanding domestic processing capacity helps mitigate transport delays for short-lived radioisotopes. The initiative supports commercial-scale production pathways under federal authorization frameworks.

QuoteOklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today announced it would advance the Groves isotope production faci...

Oklo to Advance Groves 2 Forge as Part of U.S. Department of Energy's Nuclear Energy Launch Pad Selection

Oklo's Groves isotope production facility (Groves 2 Forge) will build on the demonstration experience from the Groves Isotope Test Reactor. (Image: Oklo)

Groves 2 Forge is planned to integrate historical fragmented parts of the isotope value chain, specifically reactor irradiation with hot-cell processing capabilities, including isotope separation, product recovery, packaging, and transportation. Its focus will be on lutetium-177 and other therapeutic isotopes for use in manufacturing radiopharmaceutical treatments.

Read the full article at businesswire.com:
https://www.businesswire.com/news/home/20261013878419/en/Oklo-to-Advance-Groves-2-Forge-as-Part-of-U.S.-Department-of-Energys-Nuclear-Energy-Launch-Pad-Selection